Why work for IXICO?
Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical, biotech and CRO industry and is an emerging pioneer in digital health technologies. Our innovative and proprietary digital healthcare technologies help those involved in developing new therapies for serious diseases of the brain to collect and analyse clinically meaningful, regulatory compliant data to make rapid and informed decisions.
Our integrated product offering covers every stage of clinical drug development through to post marketing surveillance and we continue to invest in infrastructure and innovation to support our ambitious growth strategy. Our competitive advantage is our dedication to address complex medical problems through the use of smart digital solutions.
As the pharmaceutical industry looks to pave the way for personalised medicines, they will need to mine clinical trial and real-world data to tailor specific products to the individual patient. IXICO is uniquely positioned to deliver these approaches by further innovating, customising and scaling our integrated digital platform.
And our people make all this happen. We have a passionate, dedicated team, bringing together the essential skills needed to innovate and develop cutting-edge technologies, provide the support our customers need and enhance our service offering.
We are looking for a Financial Accountant to join our team who will provide effective financial reporting - both to the business and external parties - as well as identify and propose financial internal control improvements across the business, and supervise our Accounts Assistant.
If you would like to find out about working at IXICO, please contact us using the details below.
To apply for any of the posts listed above please send us your CV and covering letter by email to email@example.com stating the role you are interested in.
Please note that speculative applications from recruitment agencies will not be accepted.